Filter
3318
Filtered Results: 3318
Text search:
TB
drugs
Featured
Recommendations
280
New Publications
958
Language
Document type
No document type
2226
Studies & Reports
384
Guidelines
334
Manuals
109
Strategic & Response Plan
95
Fact sheets
52
Situation Updates
47
Training Material
43
Infographics
15
Resource Platforms
6
Brochures
3
Online Courses
3
Videos
1
Countries / Regions
India
196
Kenya
121
South Africa
112
Western and Central Europe
89
Global
83
Ethiopia
81
Uganda
78
Tanzania
77
Zambia
73
Nepal
67
Malawi
62
Nigeria
61
Eastern Europe
58
Namibia
57
Sierra Leone
54
Liberia
51
Rwanda
48
Ghana
46
Africa
45
Ukraine
42
Bangladesh
41
Myanmar / Burma
41
Lesotho
38
Latin America and the Carribbean
35
Philippines
33
Cambodia
33
Asia
31
Indonesia
31
Zimbabwe
29
Botswana
24
South–East Asia Region
23
Senegal
20
Russia
20
Colombia
17
Mozambique
17
Congo, Democratic Republic of
14
Eswatini/ Swaziland
14
Peru
13
Burkina Faso
12
Haiti
12
Germany
12
Argentina
12
Pakistan
12
East and Southern Africa
10
Tajikistan
9
Benin
9
Albania
9
Brazil
9
South Sudan
9
Armenia
8
Venezuela
8
El Salvador
7
Syria
7
West and Central Africa
7
Georgia
7
Cameroon
6
Paraguay
6
Vietnam
6
Thailand
5
Laos
5
Guinea
5
Middle East and North Africa
5
Bolivia
5
Moldova
5
Sudan
5
Afghanistan
4
Eastern Europe and Central Asia
4
Southern Africa
4
Madagascar
4
North Macedonia
3
Timor Leste/ East Timor
3
Iran
3
Estonia
3
Jordan
3
Western Pacific Region
3
Uruguay
3
Lebanon
3
Sri Lanka
3
Bhutan
3
Iraq
3
Somalia
3
Ecuador
3
Burundi
2
Morocco
2
USA
2
Saudi Arabia
2
North America
2
Papua New Guinea
2
Nicaragua
2
Yemen
2
Romania
2
Poland
2
Honduras
2
Angola
2
Guatemala
2
North Korea
1
Switzerland
1
Mexico
1
Gambia
1
Chile
1
Singapore
1
Niger
1
Mongolia
1
Qatar
1
Bulgaria
1
Dominican Republic
1
Guinea-Bissau
1
Hungary
1
Ireland
1
Gabon
1
Turkmenistan
1
Belgium
1
Maldives
1
Tunisia
1
Spain
1
Belarus
1
Belize
1
Costa Rica
1
Panama
1
Djibouti
1
Egypt
1
Greece
1
Palestine
1
Central African Republic
1
Mali
1
Libya
1
Solomon Islands
1
Authors & Publishers
Publication Years
Category
Countries
1518
Clinical Guidelines
242
Public Health
99
Women & Child Health
84
Key Resources
64
Capacity Building
39
Pharmacy & Technologies
31
Annual Report MEDBOX
2
Toolboxes
TB
756
HIV
496
AMR
133
COVID-19
79
Mental Health
70
NTDs
70
Pharmacy
65
Caregiver
55
Refugee
41
Health Financing Toolbox
38
NCDs
33
Ebola & Marburg
32
Global Health Education
31
Conflict
27
Polio
23
Disability
19
Rapid Response
18
Natural Hazards
13
Malaria
13
Planetary Health
10
Social Ethics
6
Specific Hazards
4
South Sudan
1
Cholera
1
Zika
1
Drugs and medical supplies are dispensed at the cutting edge level of the interface between the public health system and the people. Availability or lack of it brings either credit or discredit to the public health system. The primary reason for holding stocks of medicines and medical supplies in a ...
The objective of the study was the validation and implementation of GeneXpert MTB/RIF for routine use in the rapid detection of tuberculosis and sensitivity to rifampicin in clinical samples; for this, 1592 respiratory samples were collected and analyzed in the laboratory of Instituto Nacional de In...
6th edition, The NLEM 2021 contains 398 drugs molecules in different therapeutic categories.
Long Acting Muscarinic Antagonists (LAMA) such as tiotropium and glycopyrronium are used in the management of COPD1. They have been shown to improve lung function, quality of life and exercise tolerance. They have also been associated with reduced COPD-related exacerbations, associated hospitalisati...
Latent Tuberculosis Infection : Updated and consolidated guidelines for programmatic management
recommended
The consolidated guidelines are expected to provide the basis and rationale for the development of national guidelines for LTBI management, adapted to the national and local epidemiology of TB, the availability of resources, the health infrastructure and other national and local determinants. The gu...
WHO consolidated guidelines on tuberculosis: module 1: prevention: tuberculosis preventive treatment
The 2020 recommendations for the programmatic management of TB preventive treatment are the first to be released under the rubric of WHO consolidated TB guidelines (Module 1 – Prevention). The WHO consolidated TB guidelines will gradually group all TB recommendations and will be complemented by ma...
Tuberculosis cases, TB deaths
This document summarizes the results of the WHO-commissioned full value proposition for new tuberculosis (TB) vaccines. The assessment was commissioned to provide early evidence for national and global decision-makers involved in TB vaccine development and implementation, who include stakeholders in...
WHO/CDS/TB/99.272
Distr.: General, Original: French
The "Norma Técnica de Salud para la Atención integral de las Personas Afectadas por Tuberculosis" (Technical Health Standard for the Integral Care of Persons Affected by Tuberculosis)
incorporates important innovations that standardise the programmatic management of tuberculosis (TB).
Ce plan stratégique 2013- 2017 s’inscrit dans la continuité du précédent et a pour but de contribuer à la réduction de la charge de la tuberculose au Sénégal d’ici 2015 conformément aux Objectifs du Millénaire (OMD 6 Cible 8) et aux cibles du partenariat Halte à la tuberculose.
Les i...
Myanmar is one of the world’s 22 high tuberculosis (TB) burden countries, and supporting TB control in Myanmar is a global priority. This report reflects the findings, discussions, conclusions and recommendations of the fourth international review mission of the Myanmar National TB Programme (NTP)...
1.HIV infections – drug therapy. 2.Anti-HIV agents – adverse effects. 3.Anti-retroviral agents. 4.Benzoxazines – adverse effects. 5.Pregnancy. 6.Disease transmission, Vertical - prevention and control. 7.Treatment outcome. I.World Health Organization
National Tuberculosis Programme
The National Strategic Plan (NSP) for Tuberculosis (TB) 2016-2020 builds on the past experiences for the National Tuberculosis Programme and its partners. This NSP provides a roadmap for delivering quality TB prevention and care service to the entire population, ...
The National Strategic Plan (NSP) for Tuberculosis (TB) 2016-2020 builds on the past experiences for the National Tuberculosis Programme and its partners. This NSP provides a roadmap for delivering quality TB prevention and care service to the entire population, ...
2nd edition. Children with TB comprise about 10-12% of the total TB cases diagnosed in the country. This burden is likely to be higher given the challenges in diagnosing TB in children. The symptoms of TB in children mimic those of other childhood diseases. Children do not readily expectorate and th...
This is an update of a seven-year TB and Leprosy national strategic plan (TBL-NSP), which extends from 2013 to 2020. The update focuses on the plan covering from 2017-20 and is based on the 2017 external mid-term programme review key findings and recommendations; the global and national End TB strat...
Global UNIDO Project: Strengthening the local production of essential generic drugs in the least developed and developing countries
The report explores strategies for sustaining the country’s responses to the three diseases and eventually transitioning away from external funding and programmatic support. It takes stock of Kenya’s health financing landscape and identifies opportunities and challenges for sustaining effective ...
Despite being a preventable and curable infectious disease, tuberculosis (TB) has continued to elude global controll efforts. In 2023, 8.2 milion people with TB were diagnosed and notified to the WHO, the hightest number ever reported since WHO began tracking.
